THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Study slams biodefense plan

Poor organization, underfunding cited

By Robert Schlesinger
Globe Staff / January 23, 2004

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

  • E-mail|
  • Print|
  • Reprints|
  • |
Text size +

WASHINGTON -- The Pentagon's efforts at creating new vaccines and drugs to combat biological weapons are poorly organized, underfunded, and unlikely to produce successful results in the near term, if ever, according to a congressionally mandated study released yesterday. (Full Article: 638 Words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 Article
  • $9.95 4 Articles
  • $99.95 Unlimited

Boston.com top stories on Twitter

    waiting for twitterWaiting for Twitter to feed in the latest...